Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jenner

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Dental Journal|September 10, 2011
Estimating the need for dental sedation. 1. The Indicator of Sedation Need (IOSN) - a novel assessment toolP Coulthard, C M Bridgman, L Gough, et al.
British Dental Journal|September 10, 2011
Estimating the need for dental sedation. 2. Using IOSN as a health needs assessment toolI A Pretty, M Goodwin, P Coulthard, et al.
Annals of the New York Academy of Sciences|May 19, 2000
alpha-MSH can control the essential cofactor 6-tetrahydrobiopterin in melanogenesisK U Schallreuter, J Moore, D J Tobin, et al.
Anti-Cancer Drugs|April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivoM A Naylor, G E Adams, A Haigh, et al.
Bone|July 12, 2002
Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fractureF C den Boer, J A M Bramer, T J Blokhuis, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Dental Journal|September 10, 2011
Estimating the need for dental sedation. 1. The Indicator of Sedation Need (IOSN) - a novel assessment toolP Coulthard, C M Bridgman, L Gough, et al.
British Dental Journal|September 10, 2011
Estimating the need for dental sedation. 2. Using IOSN as a health needs assessment toolI A Pretty, M Goodwin, P Coulthard, et al.
Annals of the New York Academy of Sciences|May 19, 2000
alpha-MSH can control the essential cofactor 6-tetrahydrobiopterin in melanogenesisK U Schallreuter, J Moore, D J Tobin, et al.
Anti-Cancer Drugs|April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivoM A Naylor, G E Adams, A Haigh, et al.
Bone|July 12, 2002
Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fractureF C den Boer, J A M Bramer, T J Blokhuis, et al.
Pageof 2